Mirion to Present at Baird’s 2026 Global Industrial Conference

Mirion (NYSE: MIR) will present at Baird’s 2026 Global Industrial Conference on November 10, 2026, at 5:05 PM ET.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ATLANTA--(BUSINESS WIRE)-- Mirion (NYSE: MIR) announced today that Chairman and Chief Executive Officer, Thomas Logan, and Chief Financial Officer and Medical Group President, Brian Schopfer, will present at Baird’s 2026 Global Industrial Conference. The presentation will begin at 5:05 PM ET on Tuesday, November 10, 2026.

The presentation will be webcast live at Mirion's Investor Relations Page where a webcast link will be displayed under the "Events and Presentations” section. An archive of the webcast will be available as well at the same location.

About Mirion

Mirion (NYSE: MIR) is a global leader in radiation safety, science and medicine, empowering innovations that deliver vital protection while harnessing the transformative potential of ionizing radiation across a diversity of end markets. The Mirion Nuclear & Safety group provides proven radiation safety technologies that operate with precision – for essential work within R&D labs, critical nuclear facilities, and on the front lines. The Mirion Medical group solutions help enhance the delivery and ensure safety in healthcare, powering the fields of Nuclear Medicine, Radiation Therapy QA, Occupational Dosimetry, and Diagnostic Imaging. Headquartered in Atlanta (GA – USA), Mirion employs approximately 3,200 people and operates in 12 countries.

Learn more at mirion.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20261109205210/en/

For investor inquiries:
Eric Linn
ir@mirion.com

For media inquiries:
Erin Schesny
media@mirion.com

Source: Mirion

Key Terms

ionizing radiation technical

High-energy particles or waves (such as X-rays, gamma rays, or certain fast-moving particles) that can remove electrons from atoms and change chemical structures; imagine tiny, invisible billiard balls or flashes that can knock pieces out of place at the atomic level. Investors care because exposure or use of ionizing radiation drives strict safety rules, permits, cleanup costs, product approvals and liability risks for companies in healthcare, energy, manufacturing and environmental services.

dosimetry medical

Dosimetry is the measurement and calculation of how much ionizing radiation is absorbed by people, tissues, or devices, similar to a thermostat tracking temperature in different rooms to know where and how much heat is present. Investors should care because accurate dosimetry underpins safety, treatment effectiveness, regulatory approval, and liability for products and services that use radiation—affecting market access, costs, and commercial risk.